Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
After finishing at $51.97 in the prior trading day, Concentrix Corp (NASDAQ: CNXC) closed at $46.22, down -11.06%. In other words, the price has decreased by -$11.06 from its previous closing price. On the day, 1.0 million shares were traded. CNXC stock price reached its highest trading level at $51.33 during the session, while it also had its lowest trading level at $46.165.
Ratios:
Our goal is to gain a better understanding of CNXC by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 5.44 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 6.01. For the most recent quarter (mrq), Quick Ratio is recorded 1.61 and its Current Ratio is at 1.61. In the meantime, Its Debt-to-Equity ratio is 1.35 whereas as Long-Term Debt/Eq ratio is at 1.28.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Barrington Research on March 24, 2025, Reiterated its Outperform rating but revised its target price to $54 from $70 previously.
On October 03, 2024, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $70.
BofA Securities Upgraded its Underperform to Neutral on August 28, 2024, whereas the target price for the stock was revised from $65 to $85.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 30 ’25 when Twomey Cormac J sold 500 shares for $57.91 per share. The transaction valued at 28,955 led to the insider holds 37,130 shares of the business.
CORMAC TWOMEY bought 500 shares of CNXC for $28,955 on Jul 30 ’25. On Jul 08 ’25, another insider, Olivier Fabrice Duha, who serves as the Director of the company, bought 300,000 shares for $60.50 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CNXC now has a Market Capitalization of 2913653504 and an Enterprise Value of 8387525120. As of this moment, Concentrix’s Price-to-Earnings (P/E) ratio for their current fiscal year is 12.69, and their Forward P/E ratio for the next fiscal year is 3.70. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.20. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.30 while its Price-to-Book (P/B) ratio in mrq is 0.68. Its current Enterprise Value per Revenue stands at 0.871 whereas that against EBITDA is 5.945.
Stock Price History:
The Beta on a monthly basis for CNXC is 0.58, which has changed by -0.2932722 over the last 52 weeks, in comparison to a change of 0.20277917 over the same period for the S&P500. Over the past 52 weeks, CNXC has reached a high of $77.00, while it has fallen to a 52-week low of $36.28. The 50-Day Moving Average of the stock is -17.87%, while the 200-Day Moving Average is calculated to be -6.32%.
Shares Statistics:
The stock has traded on average 672.81K shares per day over the past 3-months and 659580 shares per day over the last 10 days, according to various share statistics. A total of 62.93M shares are outstanding, with a floating share count of 44.65M. Insiders hold about 29.15% of the company’s shares, while institutions hold 81.25% stake in the company. Shares short for CNXC as of 1752537600 were 6827929 with a Short Ratio of 10.15, compared to 1749772800 on 6149671. Therefore, it implies a Short% of Shares Outstanding of 6827929 and a Short% of Float of 13.04.
Dividends & Splits
In the trailing 12 months, CNXC’s forward annual dividend rate was 1.301, compared to 1.33 this year. Against a Trailing Annual Dividend Yield of 0.025033673
